Nano-X Imaging (NNOX) Capital Expenditures (2021 - 2026)
Nano-X Imaging (NNOX) posted quarterly Capital Expenditures of -$1.8 million for Q1 2026, down 237.19% year-on-year from $1.3 million in Q1 2025, and down 154.01% on a QoQ basis from $3.3 million in Q4 2025.
Nano-X Imaging (NNOX) Capital Expenditures (2021 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has reported Capital Expenditures for 6 consecutive years, with -$1.8 million the latest figure, recorded in Q1 2026.
- Quarterly Capital Expenditures fell 237.19% year-over-year to -$1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.3 million (down 153.72% YoY) and the FY2025 annual result came in at -$29000.0, down 101.05% from the prior year.
- Capital Expenditures eased to -$1.8 million in Q1 2026 per NNOX's latest filing, from $3.3 million in the prior quarter.
- Over the last five years, Capital Expenditures for NNOX reached as high as $8.2 million in Q4 2022 and fell as low as -$3.8 million in Q1 2022.
- A 5-year average of $297882.4 and a median of -$855000.0 in 2024 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2024 — Capital Expenditures surged 90.57% — and 2025, when it plunged 273.76%.
- Year by year, Capital Expenditures stood at $8.2 million in 2022, then slipped by 25.76% to $6.1 million in 2023, then retreated by 26.01% to $4.5 million in 2024, then declined by 26.84% to $3.3 million in 2025, then tumbled by 154.01% to -$1.8 million in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered -$1.8 million, $3.3 million, and -$1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.39 Bn | 175.10 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.87 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 68.22 Bn | 66.77 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 28.58 Bn | 27.46 Bn | 750.30 Mn | 76.60 Mn |
| 7 | GE HealthCare Technologies | 28.48 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.34 Bn | 2.07 Bn | -85.46 Mn |
| 10 | Nano-X Imaging | 65,191.23 | -44.16 Mn | -2.59 Mn | -1.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.78 Mn |
| Mar 31, 2026 | -1.78 Mn |
| Dec 31, 2025 | 3.29 Mn |
| Dec 31, 2025 | 3.29 Mn |
| Sep 30, 2025 | -1.74 Mn |
| Sep 30, 2025 | -1.74 Mn |
| Jun 30, 2025 | -1.05 Mn |
| Jun 30, 2025 | -1.05 Mn |
| Mar 31, 2025 | -527,000.00 |
| Mar 31, 2025 | -527,000.00 |
| Dec 31, 2024 | 4.50 Mn |
| Dec 31, 2024 | 4.50 Mn |
| Sep 30, 2024 | -734,000.00 |
| Sep 30, 2024 | -734,000.00 |
| Jun 30, 2024 | -855,000.00 |
| Jun 30, 2024 | -855,000.00 |
| Mar 31, 2024 | -141,000.00 |
| Mar 31, 2024 | -141,000.00 |
| Dec 31, 2023 | 6.08 Mn |
| Dec 31, 2023 | 6.08 Mn |